What is the Impact Factor of Thrombosis Research?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Thrombosis Research is 3.40, ranking in quartile Q2 of Web of Science (SCIE).

Is Thrombosis Research indexed in Web of Science or Scopus?

Yes, Thrombosis Research is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.046 (Q1) and an H-index of 141.

Who publishes Thrombosis Research and what is the Article Processing Charge (APC)?

Thrombosis Research is published by Elsevier Ltd. The estimated Article Processing Charge (APC) is approximately $3,472 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Thrombosis Research?

The official ISO-4 abbreviation of Thrombosis Research is "THROMB RES" with common acronym "tr". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #4,540Hybrid

Thrombosis Research

Acronym:tr

•

Abbreviation (ISO):THROMB RES

•

Identifier (ISSN):0049-3848(Print)/1879-2472(Online)

•

Publisher:Elsevier Ltd

Official Website Submission Portal Compare

Clarivate IF (2026)

3.4– 0

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Thrombosis Research

WoS Q2

Annual Impact Factor Metric

Current (2026):3.4

Scopus SJR & RankScopus Q1

1.046

#4,540

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

141

141 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate5.4%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

215articles/year

28.64% Gold OA•85.45% Original Research

Aims & Scope

Thrombosis Research is an international journal with a goal of rapid dissemination of new information on thrombosis, hemostasis, and vascular biology to advance science and clinical care. The journal publishes peer-reviewed original research, along with reviews, editorials, and opinions and critics. Both basic and clinical studies are published. Publication of research which will lead to novel approaches in diagnosis, therapy, prognosis and prevention of thrombotic and hemorrhagic diseases is given high priority.

Topics Covered (Recognized by AI)

Medicine97.5%Internal medicine90%Biology84.8%Chemistry66.7%Biochemistry60.3%Psychology55.2%Genetics54.5%Immunology53.9%Surgery52.6%Psychiatry52.1%Platelet39.4%Endocrinology30.5%Physics29.1%Cardiology28.4%Pathology25%Organic chemistry24%Thrombosis24%

Primary Research Areas

Medicine Peripheral Vascular Disease

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

HEMATOLOGY

Rank34/103

IndexSCIE

JCRSCIE2026

PERIPHERAL VASCULAR DISEASE

Rank27/100

IndexSCIE

JCISCIE2026

HEMATOLOGY

Rank28/103

IndexSCIE

JCISCIE2026

PERIPHERAL VASCULAR DISEASE

Rank29/100

IndexSCIE

Category	Index	Rank	Quartile
HEMATOLOGY	JCRSCIE	34/103	Q2
PERIPHERAL VASCULAR DISEASE	JCRSCIE	27/100	Q2
HEMATOLOGY	JCISCIE	28/103	Q2
PERIPHERAL VASCULAR DISEASE	JCISCIE	29/100	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.4

Articles / Year206

Total Citations43

2025

IF3.4

Articles / Year245

Total Citations425

2024

IF3.7

Articles / Year309

Total Citations1,556

2023

IF7.5

Articles / Year273

Total Citations2,127

2022

IF10.407

Articles / Year388

Total Citations3,595

Year	Impact Factor	Articles / Year	Total Citations
2026	3.4	206	43
2025	3.4	245	425
2024	3.7	309	1,556
2023	7.5	273	2,127
2022	10.407	388	3,595
2021	3.944	462	4,687
2020	2.869	515	22,608
2019	3.266	424	6,988
2018	2.779	498	8,606
2017	—	475	8,064
2016	—	502	10,350
2015	—	451	11,233

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,540Scopus Q1SCImago Profile

Scopus Coverage:1972-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

1.046

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

2.81

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,472 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,312

3-Year Documents838

Citable Documents633

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 5.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

2区HEMATOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Thrombosis Research (acronym: tr, abbr: THROMB RES, ISSN: 0049-3848) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Ltd in United States. The periodical holds a Journal Impact Factor (JIF) of 3.40, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.046 (Q1), an H-index of 141.

The journal enforces rigorous peer evaluation with an average review speed of 6.6周, a publication frequency of Monthly, an annual output of approximately 215 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,472 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.